首页> 外文会议>Annual meeting exposition of the Controlled Release Society >Controlled Release Formulation of Sintered Wax Matrix Tablets For Ketorolac Tromethamine: Effect of Processing Methods And Sintering
【24h】

Controlled Release Formulation of Sintered Wax Matrix Tablets For Ketorolac Tromethamine: Effect of Processing Methods And Sintering

机译:用于Ketorolac Tromethamine的烧结蜡基质片剂的控制释放制剂:加工方法和烧结的影响

获取原文

摘要

Controlled release matrix tablets for Ketorolac tromethamine, water soluble drug, were formulated using Compritol 888 ATO as rate controlling hydrophobic wax. The matrices were prepared by various methods I.e. Direct compression/ dry blending, spray drying, partial melt granulation and melt granulation. The effect of sintering was studied and was compared with control unsintered tablets. The various evaluation parameters included percentage in-vitro drug dissolution profile, wettability (contact angle measurement), surface properties (SEM), DSC and FTIR studies. Sintering was found to significantly impact the drug release profile thus making it useful tool to achieve the desired drug release.
机译:使用包含含量控制疏水性蜡的速率888 ATO配制用于酮洛克/酮己酰胺水溶性药物的控制释放基质片。通过各种方法制备基质I.。直接压缩/干混,喷雾干燥,部分熔体造粒和熔体造粒。研究了烧结的影响,并与对照未烧结的片剂进行比较。各种评价参数包括体外药物溶出度,润湿性(接触角测量),表面性质(SEM),DSC和FTIR研究的百分比。发现烧结显着影响药物释放型材,从而使其有用的工具来实现所需的药物释放。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号